Employees: 1-10
Founded date: 2019
Investors 1
| Date | Name | Website |
| 14.09.2021 | Vivo Capit... | vivocapita... |
Mentions in press and media 5
| Date | Title | Description |
| 01.06.2021 | IP GROUP PLC IP : Diurnal Group plc - Diurnal triggers $1.25m in milestone payments from Citrine Medicine | Diurnal Group plc (AIM: DNL), the specialty pharmaceutical company targeting patient needs in chronic endocrine (hormonal) diseases, announces that it has triggered payments totalling $1.25 million from Citrine Medicine, Inc. ('Citrine'), i... |
| 01.06.2021 | DIURNAL GROUP PLC Diurnal : triggers $1.25m in milestone payments from Citrine Medicine | Diurnal triggers $1.25m in milestone payments from Citrine Medicine Diurnal Group plc (AIM: DNL), the specialty pharmaceutical company targeting patient needs in chronic endocrine (hormonal) diseases, announces that it has triggered payment... |
| 12.05.2021 | IP GROUP PLC IP : Diurnal Group plc - China licensing agreement with Citrine Medicine for Efmody® | Partnership extended with China-based rare disease therapeutics company Total up-front payment and future milestones of up to $29.75 million, with double-digit royalties on sales Diurnal Group plc (AIM: DNL), the specialty pharmaceutical co... |
| 12.05.2021 | Citrine Medicine Announces Strategic Partnership to bring Efmody® to China for Use in Adrenal Insufficiency (AI), including Congenital Adrenal Hyperplasia (CAH) | |
| 14.07.2020 | China’s Citrine Medicine closes $80m in Series A Round | - |